The “United States Hospital-Acquired Pneumonia (HAP) Drugs Market” reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031. United States Hospital-Acquired Pneumonia (HAP) Drugs Market by Application Hospital-acquired pneumonia […]
Recent News